Loading...
NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma
Glioblastoma (GBM) is the most common primary intracranial malignancy. GBM still exhibits high recurrence and mortality rates even following combined treatment with surgery, radiotherapy and chemotherapy, Therefore, the identification of novel therapeutic targets is urgent. Previous research has sho...
Na minha lista:
| Udgivet i: | Oncol Rep |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6667917/ https://ncbi.nlm.nih.gov/pubmed/31322259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2019.7227 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|